ICH was established in 1990 and has since facilitated professionals from the three global regions (EU Japan and USA) to formulate
appropriate practice guidelines. The rationale behind its formation was the growing understanding within scientific communities that
the goals of pharmacovigilance services would be better met if there existed a greater degree of uniformity regarding testing and
safety regulations across the different regions.
As an essential part of patient safety, pharmacovigilance is of worldwide interest and should expand its scope and focus on new
emerging issues. The change in pharmacovigilance paradigm is a global trend and Korea has excellent infrastructure and in the near
future the paradigm of pharmacovigilance will shift in Korea. |